Montai Health
Craig Correll is an experienced biologist currently serving as Vice President and Head of Early Discovery and Immunology at Montai Therapeutics since June 2025. Prior roles include Vice President of Biology at Hyku Biosciences, and leadership positions at Theonys, Valo Health, and Repertoire Immune Medicines. Craig's extensive background in immunology began at Merck, where the role of Principal Scientist was held for nearly eight years. Early career experiences include positions at Schering-Plough Research Institute, where Craig served as both Associate Principal Scientist and Senior Scientist, and a postdoctoral fellowship at CaltechX focused on cell cycle regulation. Craig earned a PhD in Biological Chemistry from UCLA and a B.S. in Cellular and Molecular Biology from the University of Michigan.
This person is not in any teams
This person is not in any offices
Montai Health
Montai is harnessing nature's power through digital technology to treat and prevent chronic disease, hence improving health outcomes for as many people as possible. To address this crucial global concern, the business is pioneering cutting-edge technology to develop AnthromoleculeTM medications, which are derived from a privileged class ofcompounds with a history of safe human use. Our human-centered foundation can enable the rapid and repeatable development of safe, efficacious, and accessible medicines for as many diseases and people as possible by creating the world's first Anthromolecule Bioactivity Atlas, which comprehensively maps potent connections to all known biological pathways underlying disease.